Pemetrexed and cisplatin for malignant pleural mesothelioma: A new standard of care? Journal Article
| Author: | Rusch, V. W. |
| Article Title: | Pemetrexed and cisplatin for malignant pleural mesothelioma: A new standard of care? |
| Keywords: | cancer chemotherapy; treatment outcome; survival rate; clinical trial; mortality; cisplatin; cancer risk; monotherapy; note; united states; comparative study; cancer staging; antineoplastic agent; cancer incidence; neoplasm staging; metastasis; computer assisted tomography; controlled clinical trial; randomized controlled trial; antineoplastic combined chemotherapy protocols; terminally ill patient; editorial; combination chemotherapy; pathology; cancer research; standard; terminally ill; randomized controlled trials; guanine; drug derivative; malignant mesothelioma; pleura mesothelioma; mesothelioma; vitamin supplementation; medical practice; pleura tumor; folic acid; glutamates; pemetrexed; united kingdom; pleural neoplasms; environmental exposure; cyanocobalamin; glutamic acid derivative; humans; human; male; female; priority journal |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 21 |
| Issue: | 14 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2003-07-15 |
| Start Page: | 2629 |
| End Page: | 2630 |
| Language: | English |
| DOI: | 10.1200/jco.2003.02.043 |
| PUBMED: | 12860935 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 25 September 2014 -- Source: Scopus |
